Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04045964 · ClinicalTrials.gov registry record · Phase 4
Nicotine Patch as an Adjunctive Intervention to Reduce Secondhand Smoke Among NICU Families
A Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 4
- Development phase
- 32
- Enrollment target
NCT04045964: Completed Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
NCT04045964 is a Phase 4 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 32 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04045964, a Phase 4 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 32 participants
- Enrollment target
Study Summary
The purpose of this study was to explore the potential for directly targeting smoking cessation, regardless of motivation level, in a subsample of neonatal intensive care unit (NICU) parents with the ultimate goal of reducing secondhand smoke (SHS) in their homes.
Interventions
- DRUG nicotine replacement therapy (NRT)
- BEHAVIORAL motivational advice
- BEHAVIORAL Quitline referral
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2017-10-29 |
| Est. Completion | 2018-06-28 |
| Phase | Phase 4 |
What the finished NCT04045964 record still lists
NCT04045964 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 3 interventions - of which nicotine replacement therapy (NRT) is the first listed.
NCT04045964 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04045964 about?
NCT04045964 is a clinical study titled "Nicotine Patch as an Adjunctive Intervention to Reduce Secondhand Smoke Among NICU Families". The purpose of this study was to explore the potential for directly targeting smoking cessation, regardless of motivation level, in a subsample of neonatal intensive care unit (NICU) parents with the ultimate goal of reducing secondhand smoke (SHS) in their homes.
What is the current status of trial NCT04045964?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 32 participants. The study started on 2017-10-29. Estimated completion is 2018-06-28.
What interventions are being tested in trial NCT04045964?
The interventions under investigation include: nicotine replacement therapy (NRT) (DRUG), motivational advice (BEHAVIORAL), Quitline referral (BEHAVIORAL).
Who is sponsoring clinical trial NCT04045964?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04045964's enrollment target sits among peer trials
32 1534th of 2000 higher than 457 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI